News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–26
Matches
26
Sources here
18
Companies here
1
Search results Stored financial headlines

Active search

26 matching headlines

Ticker or company: ELUTMain company stories
Clear
Latest

Sahm Earnings

Elutia Secures Up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results

Elutia Inc. has secured up to $26 million in capital, without an equity offering, to fund its NXT-41x antibiotic-eluting biomatrix through commercial launch, expected in 2028. An independent survey of plastic surgeons revealed strong demand for NXT-41x, with 96% interested in adoption due to concerns about infection risk with current matrices. The company also reported its Q2 2026 …

Main company 🇺🇸 United States
Read at Sahm
Sharemaestro market context Price below Trend Line 52 weeks -55.0% ELUT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
Stock Titan Deals and strategy Main company 🇺🇸 United States

Elutia Inc. (ELUT): SilverArc Capital reports 4.9% stake in Class A shares

SilverArc Capital Management, LLC and Devesh Gandhi have reported a beneficial ownership of 2,192,980 shares of Elutia Inc. (ELUT) Class A common stock, representing a 4.9% stake. This disclosure, made via an amended Schedule 13G filing, indicates shared voting and dispositive power over these …

ELUT main company
Sharemaestro market context Price below Trend Line 52 weeks -55.0% ELUT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
seekingalpha.com Regulatory and legal Main company 🇺🇸 United States

Elutia anticipates NXT-41x clearance in 1H 2027 while targeting >80% gross margins at scale

Earnings Call Insights: Elutia (ELUT) Q2 2026 MANAGEMENT VIEW * "Four things defined this quarter. First, we're funded. Up to $26 million of additional capital with no equity offering, we believe that carries us through the NXT-41x clearance decision in the first full year …

ELUT main company
Sharemaestro market context Price below Trend Line 52 weeks -55.0% ELUT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Stock Titan Earnings Main company 🇺🇸 United States

Elutia Inc. (ELUT) stake of 2.19M shares reported by SilverArc

SilverArc Capital Management, LLC and Devesh Gandhi have reported a beneficial ownership of 2,192,980 shares of Elutia Inc. (ELUT) Class A common stock, representing a 4.9% stake. This information was disclosed in a SCHEDULE 13G SEC filing, indicating shared voting and dispositive power over …

ELUT main company
Sharemaestro market context Price below Trend Line 52 weeks -55.0% ELUT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Minichart Market update Main company 🇺🇸 United States

Elutia Inc. (ELUT) Files Form 8-K: Nasdaq-Listed Delaware Biologics Company Updates Corporate Information

Elutia, Inc. (ELUT) has filed a Form 8-K disclosing that it received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. This places the company's Nasdaq listing at risk, and it must regain compliance within a defined period to avoid delisting. …

ELUT main company
Sharemaestro market context Price below Trend Line 52 weeks -55.0% ELUT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TipRanks Analyst action Main company 🇺🇸 United States

Elutia Receives Nasdaq Notice on Listing Compliance Risk

Elutia Inc. (ELUT) received a notice from Nasdaq stating that its Class A common stock has fallen below the minimum $1.00 per share bid price for 30 consecutive business days, putting it at risk of delisting. The company has until February 2, 2027, to …

ELUT main company
Sharemaestro market context Price below Trend Line 52 weeks -55.0% ELUT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Market update Main company 🇺🇸 United States

Elutia Inc. (NASDAQ: ELUT) faces Nasdaq minimum bid price deficiency

Elutia Inc. (NASDAQ: ELUT) has received a notice from Nasdaq stating that its Class A common stock has traded below the $1.00 minimum bid price for 30 consecutive business days, failing to meet the continued listing requirement. The company has 180 calendar days, until …

ELUT main company
Sharemaestro market context Price below Trend Line 52 weeks -55.0% ELUT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Sahm Earnings Main company 🇺🇸 United States

Elutia to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026

Elutia Inc. announced it will release its second quarter 2026 financial results after market close on Thursday, August 13, 2026. A conference call and webcast will follow at 5:00 p.m. Eastern Time. Interested parties can register online to access the call details.

ELUT main company
Sharemaestro market context Price below Trend Line 52 weeks -55.0% ELUT stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Sahm Deals and strategy Main company 🇺🇸 United States

Elutia Signs Definitive Agreement to Sell SimpliDerm® in Transaction Valued at up to $11 Million, Strengthening Balance Sheet Ahead of NXT-41x Launch

Elutia Inc. has signed a definitive agreement to sell its SimpliDerm® human acellular dermal matrix business to Cellution Biologics Inc. for up to $11 million. This deal includes an $8 million cash payment at closing and up to $3 million in milestone payments. The …

ELUT main company
Sharemaestro market context Price below Trend Line 52 weeks -55.0% ELUT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context